Oncology-Hematology Associates Joins Maryland Oncology Hematology
Dec 04, 2012 (M2 PRESSWIRE via COMTEX) --
Maryland Oncology Hematology ( MOH ), united in healing with The US Oncology Network , announced today that Oncology-Hematology Associates, P.A. (OHAPA) will join its oncology and hematology practice, expanding and enhancing patient services as well as adding additional treatment locations in Clinton and Lanham, Md.
The eight board-certified OHAPA physicians will join MOH's group of 15 oncologists to offer state-of-the-art, comprehensive cancer care to oncology and hematology patients in the comfort and convenience of a patient-centered community setting.
"Our practice has been a pioneer in developing community-based oncology services dedicated to delivering the highest quality of care to patients," said Harvey Katzen, M.D., medical oncologist and president of Oncology-Hematology Associates. "In uniting with Maryland Oncology Hematology, we will be joining a group of highly-skilled, dedicated physicians who share our vision and mission of improving outcomes for patients by providing outstanding care in a patient-friendly environment."
Oncology-Hematology Associates was founded by Dr. David Haidak in 1976. During the next 35 years, he and his colleagues, Drs. Katzen and Kai-Yiu Yeung, expanded the practice to its current size, with compassionate healthcare professionals treating patients throughout Maryland.
"We are pleased to welcome the physicians of Oncology-Hematology Associates to our practice," said Jon Minford , M.D., medical oncologist and founder of Maryland Oncology Hematology. "Our collaboration with this team of like-minded, highly trained cancer specialists will allow us to expand and enhance our treatment model of providing high quality integrated, evidence-based cancer care and clinical research. Additionally, our patients will now have access to care in two more convenient locations in Maryland."
Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation's largest networks of community-based oncologists dedicated to advancing cancer care in America. By joining MOH, physicians from OHAPA will enhance their opportunities to collaborate with an expanded physician community, including network-wide physician committees, conferences, and access to The Oncology Portal, where approximately 1,000 physicians from across The Network gather in a secure online forum to learn, share best practices and collaborate on complex patient cases.
Since its founding in 1986, Maryland Oncology Hematology has evolved into a world-class treatment center offering a fully integrated approach to cancer treatment throughout the communities of Maryland and the surrounding D.C. area. Physicians, nurses and staff all collaborate to develop a unique, individualized treatment plan for each patient that utilizes cutting-edge technologies, advanced drug therapies and comprehensive supportive care to ensure each patient receives the highest quality of care for his or her particular diagnosis.
The 15 Maryland Oncology Hematology physicians practice in eight locations, providing comprehensive cancer care throughout Maryland to the communities of Columbia, Pikesville, Westminster, Silver Spring, Greenbelt, Laurel, and Wheaton, as well as Gettysburg, Pa. The recent merger with Oncology-Hematology Associates expands service offerings to Clinton and Lanham, Md. with the addition of Drs. David J. Haidak, Kai-Yiu Yeung, Harvey I. Katzen, Rita Gupta, Deepnarayan Tiwarri, Nicholas A. DeMonaco, Jose L. Mendoza and Jun F. Sun.
About Maryland Oncology Hematology
Maryland Oncology Hematology provides comprehensive, compassionate care to people challenged by cancer and blood disorders in Maryland, the surrounding D.C. area and parts of Pennsylvania. Its dedicated physicians, nurses and staff guide patients and their families through treatment options, tailoring services to each patient's unique, individual needs. Its state of the art infusion center offers a full range of chemotherapy services, laboratory testing, clinical trials and support services, provided by people who have an unwavering commitment to achieving the best possible result.
Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation's largest community-based cancer treatment and research networks focused on advancing cancer care in America. As an affiliate of The US Oncology Network, Maryland Oncology Hematology is united with approximately 1,000 physicians and 10,000 cancer professionals nationwide. Maryland Oncology Hematology participates in clinical trials through US Oncology Research, which has helped to develop 43 FDA approved cancer therapies. For more information, visit www.usoncology.com . PR Contact
Claire Crye, The US Oncology Network
Mary Beth Zaber RN, BSN, Maryland Oncology Hematology
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to firstname.lastname@example.org.
[ Back To Financial Technology's Homepage ]